ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 115

KneeMS for Juvenile Idiopathic Arthritis

Ruchik Mishra1, Catherine Yang2, Quentin Goossens3, Christopher Nichols1, Ahmet Rasim Emirdagi1, Chuoqi Chen1, Onur Selim Kilic1, Cate Garretson1, Mohammad Nikbakht1, Prabhkirat Bindra1, Lori Ponder4, Omer Inan1 and Sampath Prahalad5, 1Georgia Institute of Technology, 2Emory University, 3Georgia Institute of Technology, Atlanta, GA, 4Children's Healthcare of Atlanta, Atlanta, 5Emory + Children's Pediatric Institute, Atlanta, GA

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Friday, March 20, 2026

Title: Abstracts: Technology

Session Time: 4:43PM-4:48PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) can lead to cumulative, permanent disability from chronic inflammation without early intervention and effective treatment. It is primarily a clinical diagnosis and a diagnosis of exclusion. Highly sensitive imaging modalities, such as musculoskeletal ultrasonography and MRI, are helpful for diagnosis but have several limitations, including time constraints, cost, and the need for sedation in young children. Given the shortage of pediatric rheumatologists, which limits access to care and makes it difficult to establish regular follow-up, it is necessary to develop objective, convenient, and affordable biomarkers.
Previous studies have shown joint acoustic emissions (JAEs) as a promising biomarker for knee articular health in JIA. However, most JAEs are collected using a wired benchtop system, making monitoring outside of the clinic setting difficult. In this work, we present our low-cost, small-form-factor wearable (KneeMS) previously validated against the benchtop (Dytran (Type 3225F7) system in healthy adults, now in the JIA population during a flexion/extension (FE) activity.

Methods: We placed both the Dytran (wired) and the KneeMS (wireless) on the medial and lateral sides of the patellar tendon on each knee to record JAEs for 22 participants (44 knees). Signals from each device were band-pass filtered between 5 and 500 Hz. Since the acoustical signals appear as ‘spike-like clicks’ during a shorter period of time, we chose 30-ms windows with a 20-ms overlap to calculate the root mean square (RMS) feature. The RMS feature was then averaged over all 30-ms windows to get one RMS value per FE cycle. For each RMS value for the Dytran, we have a corresponding value for KneeMS. These pairwise values from each FE cycle across all subjects were then used to calculate the Spearman Correlation Coefficient. 

Results: We observed a high correlation between the RMS values of the Dytran and KneeMS FE cycles. We calculated the Spearman’s correlation coefficient separately for the medial and lateral sides of the knee, since the lateral side has a more impeded route than the medial. For the medial side, the Spearman Correlation coefficient was 0.936 (n = 442 FE cycles), whereas for the lateral side, it was 0.825 (n = 388 FE cycles). Both these values show a significantly (p–value < 0.001) high correlation between the two devices for the JIA population.

Conclusion: JAE obtained by the KneeMS and Dytran are highly correlated, making KneeMS a viable and low-cost (25 times cheaper) alternative to Dytran. Given that KneeMS is a low-cost, wireless wearable device, it has the potential to expand access to rheumatological care and improve management of JIA by establishing remote, JAE-based longitudinal monitoring.

Figure 1: MethodologySupporting image 1Extracting the RMS feature from filtered signals of Dytran and KneeMS for Spearman Correlation Coefficient.

Figure 2: Scatter plots for correlation and Bland-AltmanSupporting image 2Shows high and significant (p-value < 0.001) correlation between devices for both medial and lateral sides of the patellar tendon


Disclosures: R. Mishra: None; C. Yang: None; Q. Goossens: None; C. Nichols: None; A. Emirdagi: None; C. Chen: None; O. Kilic: None; C. Garretson: None; M. Nikbakht: None; P. Bindra: None; L. Ponder: None; O. Inan: Arthroba, Inc., 2, 4, 8, 10; S. Prahalad: None.

To cite this abstract in AMA style:

Mishra R, Yang C, Goossens Q, Nichols C, Emirdagi A, Chen C, Kilic O, Garretson C, Nikbakht M, Bindra P, Ponder L, Inan O, Prahalad S. KneeMS for Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/kneems-for-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/kneems-for-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology